Biocon introduces oncologic biosimilar KRABEVA in India

The biosimilar product will be used for the treatment of patients with metastatic colorectal cancer and other types of lung, kidney, cervical, ovarian and brain cancers in India.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news